Tirzepatide's dual incretin agonism produces substantial weight loss and marked improvements in insulin sensitivity, making it theoretically relevant for metabolic aspects of PCOS management
Study co-author Peter Ueda, an assistant professor of medicine at the Karolinska Institute, stressed that the final verdict on GLP-1 analogues' effect on the thyroid is still to come
They contribute to GH secretion, protein synthesis, and IGF-1 production, all of which are crucial for achieving muscle hypertrophy, maintaining good pituitary health, and promoting youthful anatomy
Full performance and physical benefits generally develop over 8 to 12 weeks of consistent use
The group shared its findings in Nature Medicine .[1] Obesity is an adiposity-based chronic disease driven by biological mechanisms, resulting in dysregulation and/or excess accumulation of adipose tissue, wrote first authors Barbara McGowan, PhD, a consultant with Guys & St